New CBM² Publications, March 2025
March 2025 publications from CBM² members included four articles co-authored by Dr. Andrew Godwin, covering research on two types of cancer—ovarian cancer and sarcoma. Listed below are links to full manuscripts from respective publishers:
- Translational Implications of The Gut Microbiome in Women with A Benign or Malignant Pelvic Mass. From: Meddocs, Annals of Obstetrics and Gynecology
- LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker. From: nature, npj Precision Oncology
- Partition-Less Digital Immunoassay Using Configurable Topographic Nanoarrays for Extracellular Vesicle Diagnosis of Ewing Sarcoma. From: ACS Nano
- Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations. Springer Nature, Journal of Cancer Research and Clinical Oncology